Abstract
Abstract A sensitive and selective semi-automated method has been developed for the determination of Remoxipride in biological fluids. The chromatographic behaviour of the basic drug is strongly improved by treatment of the C-18 bonded column with hexadecyltrimethylammonium bromide. The use of disposable precolumns permits the direct injection of 1:1 (v/v) diluted plasma or 1:9 (v/v) diluted urine. For detection, a post-column ion-pair extraction with the strongly fluorescent 9,10-dimethoxyanthracene-2-sulphonate was used. A new sandwich type phase separator helped to keep band broadening very low. The calibration curves of Remoxipride in plasma and urine show correlation coefficients of 0.9999 over at least two orders of magnitude. Detection limits are 1 ng/ml in plasma and 15 ng/ml in urine. The recovery of Remoxipride from spiked plasma and urine is 88% and 76%, respectively. The reproducibility, based on peak height measurements, for determinations in plasma (200 ng/ml) was 3.5% (RSD) within one serial run (n = 5), and 3.5% (RSD) from day to day (n = 12). For determinations in urine (160 ng/0.2ml) the reproducibility within one serial run was good, i.e., 2.2% (RSD), whereas it was rather poor from day to day, i.e., 20% (RSD).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
